miR-4324 inhibits ovarian cancer progression by targeting FEN1

被引：0
|
作者：
Haixia Wu
Youliang Yan
Jialin Yuan
Mengze Luo
Yingjian Wang
机构：
[1] Pinghu Hospital,Department of Obstetrics and Gynecology
[2] Health Science Center,Department of Obstetrics and Gynecology
[3] Shenzhen University,undefined
[4] China-Japan Union Hospital of Jilin University,undefined
来源：
Journal of Ovarian Research | / 15卷
关键词：
miR-4324; FEN1; Ovarian cancer; Proliferation; Migration; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] miR-4324 inhibits ovarian cancer progression by targeting FEN1
    Wu, Haixia
    Yan, Youliang
    Yuan, Jialin
    Luo, Mengze
    Wang, Yingjian
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [2] RETRACTED: miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2 (Retracted Article)
    Li, Hailin
    Zhu, Guiling
    Xing, Yanwei
    Zhu, Yuekun
    Piao, Daxun
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [3] Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
    Yang, Fan
    Hu, Zhigang
    Guo, Zhigang
    BIOMOLECULES, 2022, 12 (07)
  • [4] LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
    Yinling Zhao
    Donglan Yuan
    Dandan Zhu
    Tianhui Xu
    Aihua Huang
    Li Jiang
    Chiwen Liu
    Hua Qian
    Xinhua Bu
    Journal of Ovarian Research, 14
  • [5] LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
    Zhao, Yinling
    Yuan, Donglan
    Zhu, Dandan
    Xu, Tianhui
    Huang, Aihua
    Jiang, Li
    Liu, Chiwen
    Qian, Hua
    Bu, Xinhua
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [6] Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
    Wang, Manman
    Xu, Zhengtan
    Cai, Qi
    Deng, Yanmei
    Shi, Weiqiao
    Zhou, Hongyu
    Wang, Dajiang
    Li, Jian
    ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [7] RETRACTION: miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2 (Retraction of Vol 48, art no 300060519883731, 2020)
    Li, H.
    Zhu, G.
    Xing, Y.
    Zhu, Y.
    Piao, D.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
  • [8] MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression
    Yao, Lijuan
    Wang, Li
    Li, Fengxia
    Gao, Xihai
    Wei, Xuegong
    Liu, Zhihui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15198 - 15205
  • [9] FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1
    Berfelde, Johanna
    Hildebrand, Laura S.
    Kuhlmann, Lukas
    Fietkau, Rainer
    Distel, Luitpold V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [10] FEN1 promotes cancer progression of cholangiocarcinoma by regulating the Wnt/ β-catenin signaling pathway
    Xie, Yuwei
    Dong, Bingzi
    Sun, Zhaowei
    Feng, Yujie
    Wei, Zhao
    Li, Kun
    Liu, Kui
    Cao, Jingyu
    Zhu, Chengzhan
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (04) : 695 - 704
12345